We are live on ! Find out more
TRIL

Trillium Therapeutics Inc.
TRIL

Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

2 hedge funds and large institutions have $18K invested in Trillium Therapeutics Inc. in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 181 → 2 (-179)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 177

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $1.38B → $18K (-$1.38B)

Holders
2
Holders Change
-179
Holders Change %
-98.9%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
177
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$107M
2
NMC
NEA Management Company
Maryland
-$101M
3
ACA
Avoro Capital Advisors
New York
-$100M
4
EAM
Eventide Asset Management
Massachusetts
-$91.8M
5
MF
Magnetar Financial
Illinois
-$57.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
– -$14.9M -850,207 Closed
Franklin Resources
27
Franklin Resources
California
– -$14.1M -803,339 Closed
Citadel Advisors
28
Citadel Advisors
Florida
– -$14M -798,500 Closed
Northern Trust
29
Northern Trust
Illinois
– -$13.6M -772,019 Closed
DCM
30
Driehaus Capital Management
Illinois
– -$13.3M -756,426 Closed
RSCM
31
Rock Springs Capital Management
Maryland
– -$11M -628,500 Closed
QF
32
QVT Financial
New York
– -$10M -569,333 Closed
GCIA
33
Gabelli & Co Investment Advisers
New York
– -$9.89M -563,094 Closed
Vanguard Group
34
Vanguard Group
Pennsylvania
– -$9.74M -554,749 Closed
Millennium Management
35
Millennium Management
New York
– -$9.73M -553,684 Closed
WMSA
36
Weiss Multi-Strategy Advisers
New York
– -$8.76M -499,069 Closed
Man Group
37
Man Group
United Kingdom
– -$8.31M -473,310 Closed
ACM
38
ACT Capital Management
Pennsylvania
– -$8.18M -466,000 Closed
CCM
39
Crabel Capital Management
California
– -$7.44M -423,490 Closed
WIC
40
Water Island Capital
New York
– -$7.43M -423,290 Closed
Barclays
41
Barclays
United Kingdom
– -$6.86M -390,496 Closed
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
– -$6.67M -379,627 Closed
FFH
43
Fairfax Financial Holdings
Ontario, Canada
– -$5.99M -341,000 Closed
RA
44
Ramius Advisors
New York
– -$5.94M -338,042 Closed
Group One Trading
45
Group One Trading
Illinois
– -$5.83M -331,989 Closed
TAL
46
TIG Advisors LLC
New York
– -$5.68M -323,658 Closed
CS
47
Credit Suisse
Switzerland
– -$5.53M -315,046 Closed
MP
48
Mangrove Partners
Connecticut
– -$5.44M -310,000 Closed
Bank of New York Mellon
49
Bank of New York Mellon
New York
– -$5.34M -304,203 Closed
LP
50
LMR Partners
United Kingdom
– -$5.31M -302,522 Closed
1
2
3 4 5

TRIL Hedge Fund Activity: Q4 2021 in Review

2 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Trillium Therapeutics Inc. (TRIL) for Q4 2021, worth a combined $18K — down 100% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 177 funds closed out of TRIL and 1 opened new positions — a net loss of 176 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $107M sold.

  • 2 institutional investors held Trillium Therapeutics Inc. (TRIL) as of Q4 2021, down from 181 in Q3 2021.
  • Funds reported $18K of Trillium Therapeutics Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Trillium Therapeutics Inc. positions in Q4 2021 and 177 closed out, a net change of -176 holders.
  • The largest Trillium Therapeutics Inc. seller in Q4 2021 was BlackRock, an estimated $107M sold.

Based on aggregated 13F filings for Q4 2021.